The Endo International Stock price was up 5.15% to trade at 40.3470, rising from Monday’s closing price of $0.3300. Always do your due diligence before making investment decisions.Įndo International stock price. Given its current market value, delisting Endo from the Nasdaq may be the better option. However, we’ll have to wait and see if the new owners will delist the company or if they will maintain its NAsdsq listing. Its been a rough ride for Endo shareholders ever since the opioid litigation emerged, but now there is an end in sight that will see the company emerge stronger out of the bankruptcy proceedings. The deal with its creditors allowed the firm to use its cash collateral to fund its day-day activities, keeping it afloat until the bid is finalized. A popular way to gauge a stocks volatility is its 'beta'. Over the last 12 months, Endo Internationals shares have ranged in value from as little as 0.0801 up to 0.163. Endo International share price volatility. DUBLIN, J/PRNewswire/ - Endo International plc (OTC: ENDPQ) announced today that its Par Sterile Products business has begun shipping PREVDUO (neostigmine methylsulfate and glycopyrrolate injection) pre-filled syringe, the first and only FDA-approved neostigmineglycopyrrolate combination product in the U.S. Company profile page for Endomines AB including stock price, company news, press releases, executives, board members, and contact. Were not expecting Endo International to pay a dividend over the next 12 months. Research ENDPQ stock prices, stock quotes, stock trends. The company’s stock price has been in freefall since November 2021, when it was trading at $7.00, to its current price of $0.33. Ultra-Rich Buy Ultra-Luxury Counseling to Get Kids Into Harvard. Get todays stock prices, news and investor discussion about ENDO INTERNATIONAL PLC (GREY:ENDPQ). However, the “stalking horse” deal is not yet final and could be upended by parties that offer much better terms or a higher consideration.Įndo’s CEO and President, Blaise Coleman, was overjoyed, stating that the deal definitively resolves the over $8 billion in debt that the company held on its books, given that its current market capitalization is a mere $77.6 million. The deal will also see Endo set aside a trust worth $550 million to pay off specific future claims related to the opioid pandemic over the next ten years. The company has reached a sale agreement with a group of its creditors worth approximately $6 billion, including the settlement of the opioid-related cases brought against it by multiple state and local governments.

Endo stock price